Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis
I Badea, M Taylor, A Rosenberg, M Foldvari - Rheumatology, 2009 - academic.oup.com
SSc is a chronic progressive disorder of unknown aetiology characterized by excess
synthesis and deposition of collagen and other extracellular matrix components in a variety …
synthesis and deposition of collagen and other extracellular matrix components in a variety …
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
RM Knobler, LE French, Y Kim, E Bisaccia… - Journal of the American …, 2006 - Elsevier
BACKGROUND: Systemic sclerosis is a multisystemic connective tissue disease with
marked involvement of the skin and joints for which few effective evidence based therapies …
marked involvement of the skin and joints for which few effective evidence based therapies …
Diagnosis and therapy of localized scleroderma
A Kreuter, T Krieg, M Worm, J Wenzel… - JDDG: Journal der …, 2009 - Wiley Online Library
Localized scleroderma is a rare autoimmune disease with primary affection of the skin, and
occasional involvement of the fat tissue, muscle, fascia, and bone. Depending on the clinical …
occasional involvement of the fat tissue, muscle, fascia, and bone. Depending on the clinical …
Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report
AC Kerr, J Ferguson, SK Attili, PE Beattie… - Clinical and …, 2012 - academic.oup.com
Whole‐body ultraviolet (UV) A1 (340–400 nm) phototherapy was first introduced 30 years
ago, but is currently available in the UK in only three dermatology departments. A workshop …
ago, but is currently available in the UK in only three dermatology departments. A workshop …
[引用][C] UVA1 therapy for sclerodermic graft-versus-host disease of the skin
H Ständer, M Schiller, T Schwarz - Journal of the American Academy of …, 2002 - jaad.org
To the Editor: Although graft-versus-host disease (GVHD) affecting internal organs can be
treated successfully with immunosuppressive drugs and extracorporeal photopheresis …
treated successfully with immunosuppressive drugs and extracorporeal photopheresis …
Successful treatment of scleroderma with PUVA therapy
T Kanekura, S Fukumaru, S Matsushita… - The Journal of …, 1996 - Wiley Online Library
PUVA therapy was carried out on four patients with scleroderma; three of them had
cutaneous manifestations of progressive systemic sclerosis and one other exhibited …
cutaneous manifestations of progressive systemic sclerosis and one other exhibited …
Diagnostic criteria, severity classification and guidelines of localized scleroderma
Y Asano, M Fujimoto, O Ishikawa, S Sato… - The Journal of …, 2018 - Wiley Online Library
We established diagnostic criteria and severity classification of localized scleroderma
because there is no established diagnostic criteria or widely accepted severity classification …
because there is no established diagnostic criteria or widely accepted severity classification …
Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis
M Grundmann-Kollmann, R Ludwig, TM Zollner… - Journal of the American …, 2004 - Elsevier
BACKGROUND: Psoralen-UVA (PUVA) and narrowband UVB (311-nm) therapy are
considered to be first-line phototherapies for patients with moderate to severe psoriasis. To …
considered to be first-line phototherapies for patients with moderate to severe psoriasis. To …
Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric‐or adult‐onset disease
JS Mertens, MMB Seyger, W Kievit… - British Journal of …, 2015 - academic.oup.com
Summary Background Localized scleroderma (LoS) is characterized by a phase of disease
activity followed by remission. However, disease recurrences occur. Knowledge concerning …
activity followed by remission. However, disease recurrences occur. Knowledge concerning …
Ultraviolet A1‐induced downregulation of human β‐defensins and interleukin‐6 and interleukin‐8 correlates with clinical improvement in localized scleroderma
A Kreuter, J Hyun, M Skrygan, A Sommer… - British Journal of …, 2006 - academic.oup.com
Background In previous studies, distinct immunological abnormalities have been reported in
localized scleroderma (LS). Several pro‐inflammatory cytokines have been demonstrated at …
localized scleroderma (LS). Several pro‐inflammatory cytokines have been demonstrated at …